New eye drug tiespectus takes on standard treatment for wet AMD
Disease control
Not yet recruiting
This study tests a new medicine called tiespectus (also known as MK-8748 or EYE201) against the standard treatment aflibercept for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 960 people with untreated wet AMD will receive injections into the …
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC